OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
Émilie Gobeil, Ina Maltais‐Payette, Nele Taba, et al.
Metabolites (2022) Vol. 12, Iss. 5, pp. 440-440
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
Xiaolei Zhang, Lei Chen, Yang Jiang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 38

Causal relationships of metabolites with allergic diseases: a trans-ethnic Mendelian randomization study
Junhao Tu, Jinyang Wen, Qing Luo, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 12

Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer
Terry Z. Liu, Ling Wang, Shugeng Gao, et al.
International Journal of Surgery (2023) Vol. 109, Iss. 3, pp. 297-312
Open Access | Times Cited: 15

Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12809-12809
Open Access | Times Cited: 6

A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease
Qingxia Huang, S. U. Qadri, Hua Bian, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 5

Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease
Éloi Gagnon, Hasanga D. Manikpurage, Patricia L. Mitchell, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107127-107127
Open Access | Times Cited: 11

Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity
Ina Maltais‐Payette, Jérôme Bourgault, Marie‐Frédérique Gauthier, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access

Endogenous metabolites in metabolic diseases: pathophysiological roles and therapeutic implications
Mengjie Xiao, Ning Zhou, Zhen Tian, et al.
Journal of Nutrition (2025)
Closed Access

Circulating Amino Acid Changes Three Years After Bariatric Surgery
Ina Maltais‐Payette, Fannie Lajeunesse‐Trempe, Mélanie Nadeau, et al.
Metabolites (2025) Vol. 15, Iss. 5, pp. 297-297
Open Access

From NAFLD to HCC: Advances in noninvasive diagnosis
Qinchen Xu, Maoxiao Feng, Yidan Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115028-115028
Open Access | Times Cited: 6

Associations between plasma sulfur amino acids and specific fat depots in two independent cohorts: CODAM and The Maastricht Study
Elena C. Tore, Amany Elshorbagy, Frans C. H. Bakers, et al.
European Journal of Nutrition (2022)
Open Access | Times Cited: 9

Unravelling genetic architecture of circulatory amino acid levels, and their effect on risk of complex disorders
Leila Abar, Verena Zuber, Georg Otto, et al.
NAR Genomics and Bioinformatics (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 1

Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases
Junhang Li, Xiang Ma, Cuihua Yin
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial
Anne-Laure Agrinier, Arianne Morissette, Laurence Daoust, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101682-101682
Open Access | Times Cited: 1

Circulating Metabolomic and Lipidomic Signatures Identify a Type 2 Diabetes Risk Profile in Low-Birth-Weight Men with Non-Alcoholic Fatty Liver Disease
Line O. Elingaard-Larsen, Sofie Olund Villumsen, Louise Justesen, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1590-1590
Open Access | Times Cited: 3

Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease
Xing Wang, Dianpeng Zhao, Lichao Cheng, et al.
Medicine (2023) Vol. 102, Iss. 38, pp. e34638-e34638
Open Access | Times Cited: 3

β-triketone herbicide exposure cause tyrosine and fat accumulation in Caenorhabditis elegans
Nida Moin, Ravindra Singh Thakur, Swati Singh, et al.
Chemosphere (2023) Vol. 326, pp. 138353-138353
Closed Access | Times Cited: 2

Electronic structure and molecular properties of nitisinone and mesotrione in water
Richard Imrich, Juraj Štofko, Roman Boča, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 12
Open Access | Times Cited: 2

Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
Hwi Young Kim, Da Jung Kim, Hye Ah Lee, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 444-444
Open Access | Times Cited: 1

Novel genetic insights into the roles of amino acids in metabolic dysfunction-associated steatotic liver disease
Jun Liu, Yuxuan Chen, Jin Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1 - Next Page

Scroll to top